Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 107

Sort by

Sort Order Select

Journal Articles

An Open Label Study of Alpn-101, a First-in-Class Dual CD28/ICOS Antagonist, in Subjects with Steroid-Resistant or Steroid-Refractory Acute Graft Versus Host Disease (aGVHD)

Jing Yang, PhD, Jan L. Hillson, MD, Kristi L. Manjarrez, Jennifer R. Wiley, DRSc, Gary D. Means, PhD, Stacey R. Dillon, PhD, Stanford L. Peng, MD,PhD

Blood (2019) 134 (Supplement_1): 372.

https://doi.org/10.1182/blood-2019-126034

Published: 2019

Journal Articles

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Mohammed Abdullah Alsheef, MD, Kamal Gazal, MD, Nahar Alenizi, MD, Khalid Qushmaq, MD, Mukhtar Alomar, PharmD, Ghaydaa Juma Kullab, MD, Abdul Rehman Z. Zaidi, MBBS

Blood (2019) 134 (Supplement_1): 4955.

https://doi.org/10.1182/blood-2019-130548

Published: 2019

Journal Articles

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Effrosyni Apostolidou, MD, PhD, Masumeh Hatami, MD, Sean.I. Savitz, MD, Eric Thomas, MD, Priya Khatri, MBA, MPH, Alicia Zha, MD

Blood (2019) 134 (Supplement_1): 3397.

https://doi.org/10.1182/blood-2019-124521

Published: 2019

Journal Articles

Low-Grade Inflammation in Hemophilia

Lynn M Knowles, PhD, Hermann Eichler, Jan Pilch, MD

Blood (2019) 134 (Supplement_1): 1115.

https://doi.org/10.1182/blood-2019-125127

Published: 2019

Journal Articles

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Amber C. King, PharmD, BCOP, Jae H. Park, MD, Mark B. Geyer, MD

Blood (2019) 134 (Supplement_1): 3887.

https://doi.org/10.1182/blood-2019-128506

Published: 2019

Journal Articles

Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable Remissions

Aaron D Goldberg, MD PhD, Catherine C. Coombs, MD, Eunice S. Wang, MD, Roland B. Walter, MD PhD MS, Chatchada Karanes, MD, Carlos Enrique Vigil, MD, Boo Messahel, MD, Richard M. Stone, MD, Robert H. Collins, MD

Blood (2019) 134 (Supplement_1): 1326.

https://doi.org/10.1182/blood-2019-130863

Published: 2019

Journal Articles

Initial Evaluation of Adolescent Females Hospitalized with Heavy Menstrual Bleeding

Lauren E Amos, MD, Shannon L Carpenter, MD

Blood (2018) 132 (Supplement 1): 1216.

https://doi.org/10.1182/blood-2018-99-119576

Published: 2018

Journal Articles

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia

Charles Gaulin, MBBS, Angela Chan, MSN, AGPCNP-BC, Mark Blaine Geyer, MD, Jae H. Park, MD, Simon Mantha, MDMPH, Martin S. Tallman, MD

Blood (2018) 132 (Supplement 1): 1217.

https://doi.org/10.1182/blood-2018-99-110741

Published: 2018

Journal Articles

Combinatorial Approaches to Overcome Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors

David J Young, MD PhD, Jun O Liu, PhD, Donald Small, MD PhD

Blood (2018) 132 (Supplement 1): 1362.

https://doi.org/10.1182/blood-2018-99-118820

Published: 2018

Journal Articles

C-Reactive Protein Monitoring Can Predict Neutropenic Fever during Autologous Hematopoietic Stem Cell Transplantation for Mutliple Myeloma

Vidya Kollu, MD, Sarah L Mott, Lindsay Dozeman, Fnu Rafiullah, MD, Umar Farooq, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD

Blood (2017) 130 (Supplement 1): 5529.

https://doi.org/10.1182/blood.V130.Suppl_1.5529.5529

Published: 2017

Journal Articles

A Novel Method for Overcoming Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors

David J Young, MD PhD, Donald Small, MD PhD

Blood (2017) 130 (Supplement 1): 1241.

https://doi.org/10.1182/blood.V130.Suppl_1.1241.1241

Published: 2017

Journal Articles

Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis

Piyapong Kanya, MD, Ekarat Rattarittamrong, MD, Ornkamon Wongtagan, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD, Adisak Tantiworawit, MD, Lalita Norasetthada, MD

Blood (2017) 130 (Supplement 1): 4207.

https://doi.org/10.1182/blood.V130.Suppl_1.4207.4207

Published: 2017

Journal Articles

Plasma Proteolytic Cascade Activation and Control during Neonatal Cardiopulmonary Bypass Surgery

Susan A. Maroney, DVM, PhD, Julie A. Peterson, PhD, Wes Zwifelhofer, BS, Rachel Bercovitz, MD MS, Ronald K. Woods, MD PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 2356.

https://doi.org/10.1182/blood.V130.Suppl_1.2356.2356

Published: 2017

Journal Articles

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Ahmet Yalcinkaya, MD, Selma Unal, MD, Yesim Oztas, MD PhD

Blood (2017) 130 (Supplement 1): 2240.

https://doi.org/10.1182/blood.V130.Suppl_1.2240.2240

Published: 2017

Journal Articles

Mediators of Disseminated Intravascular Coagulation: Molecular Mechanisms

Patricia C. Liaw, PhD

Blood (2017) 130 (Supplement 1): SCI-2.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-2.SCI-2

Published: 2017

Journal Articles

Markers for Increased Thrombotic Risk within the Complete Blood Count

Sæmundur Rögnvaldsson, Sigrún H. Lund, PhD, Malin Hultcrantz, MD PhD, Signý Vala Sveinsdóttir, MD PhD, Guðný Eiríksdóttir, Tamara B Harris, MD, Vilmundur Guðnason, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 1429.

https://doi.org/10.1182/blood.V128.22.1429.1429

Published: 2016

Journal Articles

FLT3 TKI Are Differentially Affected By Both Plasma Binding and Stromal Survival Factors

Young J David, MD PhD, Hayley S Ma, PhD, Donald Small, MD PhD

Blood (2016) 128 (22): 1570.

https://doi.org/10.1182/blood.V128.22.1570.1570

Published: 2016

Journal Articles

Hemophagocytic Syndrome in Systemic Lupus Erythematosus : A Monocentric Review of 13 Cases

Zoubida Tazi Mezalek, professor, Wafaa Ammouri, Meriem Bourkia, Hicham Harmouche, Mouna Maamar, Mohammed Adnaoui

Blood (2016) 128 (22): 3687.

https://doi.org/10.1182/blood.V128.22.3687.3687

Published: 2016

Journal Articles

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Kristen M Scheitler, Post-Sophomore Fellow, Emily A Coberly, MD, A. Mosharraf Hossain, MD, Richard D Hammer, MD

Blood (2016) 128 (22): 4989.

https://doi.org/10.1182/blood.V128.22.4989.4989

Published: 2016

Journal Articles

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Akiko Negoro, MD, Heiwa Kanamori, MD, Jun Aoki, MD, Satoshi Koyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Hideaki Nakajima, MD

Blood (2016) 128 (22): 5853.

https://doi.org/10.1182/blood.V128.22.5853.5853

Published: 2016

NARROW

An Open Label Study of Alpn-101, a First-in-Class Dual CD28/ICOS Antagonist, in Subjects with Steroid-Resistant or Steroid-Refractory Acute Graft Versus Host Disease (aGVHD)

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Low-Grade Inflammation in Hemophilia

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable Remissions

Initial Evaluation of Adolescent Females Hospitalized with Heavy Menstrual Bleeding

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia

Combinatorial Approaches to Overcome Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors

C-Reactive Protein Monitoring Can Predict Neutropenic Fever during Autologous Hematopoietic Stem Cell Transplantation for Mutliple Myeloma

A Novel Method for Overcoming Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors

Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis

Plasma Proteolytic Cascade Activation and Control during Neonatal Cardiopulmonary Bypass Surgery

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Mediators of Disseminated Intravascular Coagulation: Molecular Mechanisms

Markers for Increased Thrombotic Risk within the Complete Blood Count

FLT3 TKI Are Differentially Affected By Both Plasma Binding and Stromal Survival Factors

Hemophagocytic Syndrome in Systemic Lupus Erythematosus : A Monocentric Review of 13 Cases

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only